|
L-theanine is Effective in Lessening Positive Symptoms, and improving Sleep Quality in patients with schizophrenia
|
|
351
|
60499
|
September 11, 2020
|
|
Please Read - Intro to Schizophrenia News Discussions
|
|
5
|
10057
|
February 9, 2017
|
|
Dopaminergic, Noradrenergic, Adrenal, and Thyroid Abnormalities in Psychotic and Affective Disorders
|
|
1
|
20
|
October 27, 2020
|
|
Neurophysiological Face Processing Deficits in Patients With Chronic Schizophrenia: An MEG Study
|
|
2
|
15
|
October 27, 2020
|
|
Association between the COMT Val158Met polymorphism and antipsychotic efficacy in schizophrenia: an updated meta-analysis
|
|
0
|
12
|
October 27, 2020
|
|
Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis Somw
|
|
0
|
10
|
October 27, 2020
|
|
Are we all a bit mad here
|
|
19
|
181
|
October 27, 2020
|
|
Flexible Assertive Community Treatment Shows Promise for Patients With SMI
|
|
1
|
41
|
October 27, 2020
|
|
Discovery of new cell may be key to treating incurable neurological diseases
|
|
1
|
49
|
October 27, 2020
|
|
Little Congruence Between Categorical- and Dimensional-Based Diagnoses of Psychotic Disorders
|
|
0
|
24
|
October 26, 2020
|
|
Article on pivoting and adaptation
|
|
0
|
33
|
October 26, 2020
|
|
Explaining the Phases of Schizophrenia: Symptoms, Treatment & More
|
|
0
|
31
|
October 26, 2020
|
|
Abnormal visual representations associated with confusion of perceived facial expression in schizophrenia with social anxiety disorder
|
|
4
|
62
|
October 26, 2020
|
|
As a reminder, here's the FAQ
|
|
1
|
93
|
October 25, 2020
|
|
Can we treat cognitive deficits in schizophrenia through electrical brain stimulation?
|
|
6
|
126
|
October 25, 2020
|
|
Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study
|
|
3
|
79
|
October 25, 2020
|
|
Overconfidence in social cognitive decision making: Correlations with social cognitive and neurocognitive performance in participants with schizophrenia and healthy individuals
|
|
2
|
63
|
October 24, 2020
|
|
Schizotypy, neuroticism, and saccadic eye movements: New data and meta-analysis
|
|
0
|
39
|
October 24, 2020
|
|
Acute and Long-term Memantine Add-on Treatment to Risperidone Improves Cognitive Dysfunction in Patients with Acute and Chronic Schizophrenia
|
|
0
|
49
|
October 24, 2020
|
|
Adjunct high-frequency transcranial random noise stimulation over the lateral prefrontal cortex improves negative symptoms of schizophrenia: A randomized, double-blind, sham-controlled pilot study
|
|
0
|
46
|
October 24, 2020
|
|
Psychological interventions for acute psychiatric inpatients with schizophrenia-spectrum disorders: A systematic review and meta-analysis
|
|
0
|
42
|
October 23, 2020
|
|
Neurobiology of glycine transporters: From molecules to behavior
|
|
0
|
47
|
October 23, 2020
|
|
The value of visioning: Augmenting EMDR with alpha-band alternating bilateral photic stimulation for trauma treatment in schizophrenia
|
|
0
|
41
|
October 23, 2020
|
|
The effect of negative automatic thoughts on hope in patients with schizophrenia
|
|
3
|
72
|
October 23, 2020
|
|
Large-Scale Evidence for an Association Between Peripheral Inflammation and White Matter Free Water in Schizophrenia and Healthy Individuals
|
|
0
|
40
|
October 23, 2020
|
|
[The effect of various forms of folates on cognitive functions in patients
|
|
3
|
87
|
October 23, 2020
|
|
Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers
|
|
0
|
44
|
October 23, 2020
|
|
[The double-blind randomized placebo-controlled trial of N-acetylcysteine use
|
|
4
|
74
|
October 22, 2020
|
|
Genetics of schizophrenia, according to ClinVar
|
|
10
|
176
|
October 22, 2020
|
|
Childhhood Trauma in Schizophrenia Spectrum Disorders: Dissociative, Psychotic Symptoms, and Suicide Behavior
|
|
1
|
58
|
October 22, 2020
|